1. Home
  2. ELTK vs FLNA Comparison

ELTK vs FLNA Comparison

Compare ELTK & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eltek Ltd.

ELTK

Eltek Ltd.

HOLD

Current Price

$9.20

Market Cap

53.1M

Sector

Technology

ML Signal

HOLD

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$1.53

Market Cap

61.8M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ELTK
FLNA
Founded
1970
1998
Country
Israel
United States
Employees
N/A
20
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
53.1M
61.8M
IPO Year
1998
N/A

Fundamental Metrics

Financial Performance
Metric
ELTK
FLNA
Price
$9.20
$1.53
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
8.1K
418.7K
Earning Date
05-19-2026
05-13-2026
Dividend Yield
2.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.18
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$48.71
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.30
$1.16
52 Week High
$12.19
$2.03

Technical Indicators

Market Signals
Indicator
ELTK
FLNA
Relative Strength Index (RSI) 65.01 55.64
Support Level $8.38 $1.16
Resistance Level $9.37 $1.80
Average True Range (ATR) 0.53 0.09
MACD 0.14 0.05
Stochastic Oscillator 81.43 79.16

Price Performance

Historical Comparison
ELTK
FLNA

About ELTK Eltek Ltd.

Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. The company manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. The geographic areas of the company are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: